Yea Sean, I emailed that exact question today around 11am
Yea Sean, I emailed that exact question today around 11am but with all the technicalities disrupting the call, it never got answered. Here was the question I asked without my name here but they know who I am
" My question for the webcast to me is a very important one. It's a vital statistic that we all should now. How many patients have been given Leronlimab in the HIV trials that got Covid. The smaller the number the better and its so important for future patients to know this vital statistic as it proves Leronlimab works for HIV patients beyond HIV. Not getting Covid while on Leronlimab is a tremendous accomplishment.
I also would like to know and I feel Cytodyn would be in better shape knowing that with proven results that after being administered Leronlimab for any of our trials to date and especially for the up coming Brazil trials, how many have gone on to get Long Haulers syndrome or PASC. Wouldn't that be a tremendous secondary end point to know and if they are minimal, would surely be something the world needs to know?
Thank you in advance Dr. Pourhassan, Dr. Kelly & Dr. Recknor for all you have done and without all of you at the helm, especially in the very beginning in 2012 with Dr. Pourhassan buying this great molecule from Madden, where would Cytodyn be today. Great job and I'm proud of all of you for be so tenacious in your drive to bring Leronlimab to fruition. Bravo gentleman.
Best to you all and stay safe and well,
XXXXXXX
Now, all of you, don't laugh about my pay grade as I am still working and hope to work til I'm 80, ha ha
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Five million patient histories are not a flashy product demo. They are a serious raw-material advantage, provided the data can be protected, organized, and made useful without turning clinical research into a carnival of loose claims. That is the real weight behind nference's long-term collaboration with Cedars-Sinai, announced November 20, 2026. The pair plan to build a...
Continue Reading
A Boardroom Hire With Some Actual Weight PayPal did not go hunting for another decorative résumé. Brian J. Lee, set to join the board on November 30, 2026, spent decades inside Goldman Sachs, including a stint as chief risk officer from 2019 through January 2025. For a payments company trying to sharpen its financial-services identity, that is a serious piece of...
Continue Reading
A frozen turkey is not a grand strategy deck, thank goodness; it is dinner for a household that might be feeling the squeeze. Story Cannabis plans to hand out 840 of them on Tuesday, Nov. 24, splitting the giveaway between Columbus and Cleveland with former Ohio State and Dallas Cowboys running back Michael Wiley joining employees and volunteers. In a cannabis business...
Continue Reading
One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...
Continue Reading
Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...
Continue Reading
Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...
Continue Reading
A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....
Continue Reading
A $166 million average book is not a cute training-program statistic. It says SEIA’s advisors aged 30 to 39 are already carrying serious client responsibility, and that matters because the registered investment advisory business is headed into a succession crunch nobody can solve with a glossy recruiting brochure. You Cannot Hand Off Trust Like a Spare Key Clients may...
Continue Reading
Cherry blossoms are not normally the sort of thing that gets my investor blood moving, but a ship deployment decision does. Holland America Line is sending Eurodam into Asia for its first season there from September 2028 through May 2029, and it is plainly trying to sell more than transportation between postcard ports. The pitch is time: five new ports, 14 ports with...
Continue Reading
Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...
Continue Reading
Top 5 Most Recently Viewed Articles
An Unseen Complication: The Problem with Jaw Clicking When something's wrong, especially with the body's mechanics, there's usually a sound telling you so. Hearing a click every time you chew? Dr. Georgia Knotek from Greenfield knows all about it. In a recent HelloNation article, she dives into this unsettling symptom that many shrug off but shouldn't. Let's talk about...
Continue Reading
Aduro Clean Technologies Enhances Leadership and Marketing Strategies Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (NASDAQ: ADUR), has made significant strides in its journey towards commercialization. The Company, which specializes in clean technology to recycle lower-value feedstocks like waste plastics and heavy bitumen, is strengthening its team as...
Continue Reading
Katahdin Bankshares Corp. Declares Fourth Quarter Dividend Katahdin Bankshares Corp. (OTCQX: KTHN), the parent company of Katahdin Trust Company, recently announced an exciting update regarding its quarterly dividend. In an effort to reward its loyal shareholders, the company has declared a cash dividend of $0.2025 per share for the fourth quarter. This payment is...
Continue Reading
Class Action Lawsuit Filed Against Symbotic Inc. In recent developments, a law firm recognized nationally, Bronstein, Gewirtz & Grossman, LLC, has taken a significant step by notifying investors about a class action lawsuit involving Symbotic Inc. (NASDAQ: SYM). This legal action targets certain officers of the company while focusing on protecting the interests of...
Continue Reading
Persona-Triangle Appoints Arron Yount as CEO Persona-Triangle recently announced the appointment of Arron B. Yount as its new Chief Executive Officer. With a robust background in operations and a history of enhancing multi-divisional businesses, Yount is expected to lead the company into a new chapter of growth and innovation. Leadership Experience Driving Change Bringing...
Continue Reading